Correlation Between MorphoSys and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both MorphoSys and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MorphoSys and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MorphoSys AG ADR and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on MorphoSys and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MorphoSys with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MorphoSys and Mineralys Therapeutics,.

Diversification Opportunities for MorphoSys and Mineralys Therapeutics,

0.68

Correlation Coefficient

MorphoSys  Mineralys Therapeutics,

Poor diversification

The 3 months correlation between MorphoSys and Mineralys is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding MorphoSys AG ADR and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and MorphoSys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MorphoSys AG ADR are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of MorphoSys i.e., MorphoSys and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between MorphoSys and Mineralys Therapeutics,

If you would invest (100.00) in MorphoSys AG ADR on October 17, 2024 and sell it today you would earn a total of  100.00  from holding MorphoSys AG ADR or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	0.0%
Values	Daily Returns

MorphoSys AG ADR  vs.  Mineralys Therapeutics, Common

MorphoSys AG ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MorphoSys AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MorphoSys is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with MorphoSys and Mineralys Therapeutics,

The main advantage of trading using opposite MorphoSys and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MorphoSys position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind MorphoSys AG ADR and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.